Cardiometabolic Therapeutics · Prescription Drugs
Esperion: Ownership & structure
Esperion operates through 1 legal entity in 1 country.
Data updated Nov 22, 2026 · Back to the company report
Owners & entities
Esperion operates through 1 legal entity in 1 country.
Legal entities1 in 1 country
Esperion Therapeutics, Inc.
operator
US
Large holders (13D / 13G)holders of 5% or more, their newest filing
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months
Insiders bought $0 (0 people) and sold $576k (3 people) in the last 12 months.
Sold · President and CEO
53,588 shares at $3.16 · Jun 2026
$169k
Sold · Chief Legal Officer
11,824 shares at $3.16 · Jun 2026
$37k
Sold · Chief Financial Officer
10,773 shares at $3.16 · Jun 2026
$34k
Sold · President and CEO
25,578 shares at $2.72 · Mar 2026
$70k
Sold · Chief Financial Officer
6,424 shares at $2.71 · Mar 2026
$17k
Sold · Chief Legal Officer
5,708 shares at $2.70 · Mar 2026
$15k
Sold · General Counsel
1,689 shares at $2.88 · Jan 2026
$4.9k
Sold · President and CEO
48,244 shares at $3.67 · Dec 2025
$177k
Sold · Chief Financial Officer
7,337 shares at $3.67 · Dec 2025
$27k
Sold · General Counsel
6,517 shares at $3.67 · Dec 2025
$24k
Holders and shares as each register or filing states them.
Connections
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

ARCHIMEDVia a fund

Longitude CapitalVia a fund
78 portfolio companies: Zenas BioPharma, Mobia Medical, Inc. and 76 more

Aisling CapitalVia a fund

Oak Investment PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
